200 related articles for article (PubMed ID: 31136950)
21. Enhanced in vitro maturation of fetal mouse liver cells with oncostatin M, nicotinamide, and dimethyl sulfoxide.
Sakai Y; Jiang J; Kojima N; Kinoshita T; Miyajima A
Cell Transplant; 2002; 11(5):435-41. PubMed ID: 12382670
[TBL] [Abstract][Full Text] [Related]
22. A pump-free microfluidic 3D perfusion platform for the efficient differentiation of human hepatocyte-like cells.
Ong LJY; Chong LH; Jin L; Singh PK; Lee PS; Yu H; Ananthanarayanan A; Leo HL; Toh YC
Biotechnol Bioeng; 2017 Oct; 114(10):2360-2370. PubMed ID: 28542705
[TBL] [Abstract][Full Text] [Related]
23. Hepatic differentiation of human pluripotent stem cells on human liver progenitor HepaRG-derived acellular matrix.
Kanninen LK; Porola P; Niklander J; Malinen MM; Corlu A; Guguen-Guillouzo C; Urtti A; Yliperttula ML; Lou YR
Exp Cell Res; 2016 Feb; 341(2):207-17. PubMed ID: 26854693
[TBL] [Abstract][Full Text] [Related]
24. Development of a DsRed-expressing HepaRG cell line for real-time monitoring of hepatocyte-like cell differentiation by fluorescence imaging, with application in screening of novel geometric microstructured cell growth substrates.
Uta M; Sima LE; Hoffmann P; Dinca V; Branza-Nichita N
Biomed Microdevices; 2017 Mar; 19(1):3. PubMed ID: 28070697
[TBL] [Abstract][Full Text] [Related]
25. Generation of hepatic spheroids using human hepatocyte-derived liver progenitor-like cells for hepatotoxicity screening.
Wang Z; Li W; Jing H; Ding M; Fu G; Yuan T; Huang W; Dai M; Tang D; Zeng M; Chen Y; Zhang H; Zhu X; Peng Y; Li Q; Yu WF; Yan HX; Zhai B
Theranostics; 2019; 9(22):6690-6705. PubMed ID: 31588244
[No Abstract] [Full Text] [Related]
26. Selecting Cells for Bioartificial Liver Devices and the Importance of a 3D Culture Environment: A Functional Comparison between the HepaRG and C3A Cell Lines.
van Wenum M; Adam AA; Hakvoort TB; Hendriks EJ; Shevchenko V; van Gulik TM; Chamuleau RA; Hoekstra R
Int J Biol Sci; 2016; 12(8):964-78. PubMed ID: 27489500
[TBL] [Abstract][Full Text] [Related]
27. Transdifferentiation of hepatocyte-like cells from the human hepatoma HepaRG cell line through bipotent progenitor.
Cerec V; Glaise D; Garnier D; Morosan S; Turlin B; Drenou B; Gripon P; Kremsdorf D; Guguen-Guillouzo C; Corlu A
Hepatology; 2007 Apr; 45(4):957-67. PubMed ID: 17393521
[TBL] [Abstract][Full Text] [Related]
28. Increased hepatic functionality of the human hepatoma cell line HepaRG cultured in the AMC bioreactor.
Nibourg GA; Hoekstra R; van der Hoeven TV; Ackermans MT; Hakvoort TB; van Gulik TM; Chamuleau RA
Int J Biochem Cell Biol; 2013 Aug; 45(8):1860-8. PubMed ID: 23770120
[TBL] [Abstract][Full Text] [Related]
29. The HepaRG cell line: a unique in vitro tool for understanding drug metabolism and toxicology in human.
Andersson TB; Kanebratt KP; Kenna JG
Expert Opin Drug Metab Toxicol; 2012 Jul; 8(7):909-20. PubMed ID: 22568886
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of CYP3A4 inhibition and hepatotoxicity using DMSO-treated human hepatoma HuH-7 cells.
Liu Y; Flynn TJ; Xia M; Wiesenfeld PL; Ferguson MS
Cell Biol Toxicol; 2015 Oct; 31(4-5):221-30. PubMed ID: 26377104
[TBL] [Abstract][Full Text] [Related]
31. Differentiation of liver progenitor cell line to functional organotypic cultures in 3D nanofibrillar cellulose and hyaluronan-gelatin hydrogels.
Malinen MM; Kanninen LK; Corlu A; Isoniemi HM; Lou YR; Yliperttula ML; Urtti AO
Biomaterials; 2014 Jun; 35(19):5110-21. PubMed ID: 24698520
[TBL] [Abstract][Full Text] [Related]
32. Transcriptional, Functional, and Mechanistic Comparisons of Stem Cell-Derived Hepatocytes, HepaRG Cells, and Three-Dimensional Human Hepatocyte Spheroids as Predictive In Vitro Systems for Drug-Induced Liver Injury.
Bell CC; Lauschke VM; Vorrink SU; Palmgren H; Duffin R; Andersson TB; Ingelman-Sundberg M
Drug Metab Dispos; 2017 Apr; 45(4):419-429. PubMed ID: 28137721
[TBL] [Abstract][Full Text] [Related]
33. Human Hepatic HepaRG Cells Maintain an Organotypic Phenotype with High Intrinsic CYP450 Activity/Metabolism and Significantly Outperform Standard HepG2/C3A Cells for Pharmaceutical and Therapeutic Applications.
Nelson LJ; Morgan K; Treskes P; Samuel K; Henderson CJ; LeBled C; Homer N; Grant MH; Hayes PC; Plevris JN
Basic Clin Pharmacol Toxicol; 2017 Jan; 120(1):30-37. PubMed ID: 27285124
[TBL] [Abstract][Full Text] [Related]
34. lnc-RHL, a novel long non-coding RNA required for the differentiation of hepatocytes from human bipotent progenitor cells.
Prabhakar B; Lee S; Bochanis A; He W; Manautou JE; Rasmussen TP
Cell Prolif; 2021 Feb; 54(2):e12978. PubMed ID: 33393114
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis B Virus Infection of HepaRG Cells, HepaRG-hNTCP Cells, and Primary Human Hepatocytes.
Ni Y; Urban S
Methods Mol Biol; 2017; 1540():15-25. PubMed ID: 27975304
[TBL] [Abstract][Full Text] [Related]
36. Optimization of the HepaRG cell model for drug metabolism and toxicity studies.
Anthérieu S; Chesné C; Li R; Guguen-Guillouzo C; Guillouzo A
Toxicol In Vitro; 2012 Dec; 26(8):1278-85. PubMed ID: 22643240
[TBL] [Abstract][Full Text] [Related]
37. A Preliminary Investigation of Embedding In Vitro HepaRG Spheroids into Recombinant Human Collagen Type I for the Promotion of Liver Differentiation.
Liao FC; Wang YK; Cheng MY; Tu TY
Polymers (Basel); 2022 May; 14(9):. PubMed ID: 35567092
[TBL] [Abstract][Full Text] [Related]
38. The effect of rat acute-liver-failure plasma on HepaRG cells.
Hoekstra R; Nibourg GA; van der Hoeven TV; Ackermans MT; Hakvoort TB; van Gulik TM; Oude Elferink RP; Chamuleau RA
Int J Artif Organs; 2012 Nov; 35(11):1006-14. PubMed ID: 23065880
[TBL] [Abstract][Full Text] [Related]
39. The role of epigenetic modifiers in extended cultures of functional hepatocyte-like cells derived from human neonatal mesenchymal stem cells.
Cipriano M; Correia JC; Camões SP; Oliveira NG; Cruz P; Cruz H; Castro M; Ruas JL; Santos JM; Miranda JP
Arch Toxicol; 2017 Jun; 91(6):2469-2489. PubMed ID: 27909741
[TBL] [Abstract][Full Text] [Related]
40. Liver X receptor α (LXRα/NR1H3) regulates differentiation of hepatocyte-like cells via reciprocal regulation of HNF4α.
Chen KT; Pernelle K; Tsai YH; Wu YH; Hsieh JY; Liao KH; Guguen-Guillouzo C; Wang HW
J Hepatol; 2014 Dec; 61(6):1276-86. PubMed ID: 25073010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
